L.E. Kandalaft

Discipline

Psychologie (2) Histoire, Philosophie et Sociologie des sciences (2) Sociologie (1) Sciences de l'information et de la communication (1) Economies et finances (1)

Type de document

Articles (37) Recensions (10)

Co-auteur

Date

Source

Mot-clé

Cancer (27) cancer (26) Cancer (26) Immunotherapy (26) Immunotherapy (26) Treatment (19) Patients (17) Patients (17) T cells (16) Vaccines (13) Vaccination (13) Cells (13) Vaccination (13) Tumors (12) Tumors (12) Mice (11) Human beings (11) thérapie (10) Therapeutics (10) Antigens (10) Lymphocytes (9) Cancer vaccines (9) abords (agglomération) (8) Dendritic cells (8) Animals (8) Use (8) modèle (7) analyse (7) Development (7) Strategy (7)

Documents écrit par L.E. Kandalaft (37) | parle de L.E. Kandalaft (0)

PGE2 limits effector expansion of tumour-infiltrating stem-like CD8+ T cells.
M. Morotti et al.
Immunopeptidomics-based identification of naturally presented non-canonical circRNA-derived peptides.
H.J. Ferreira et al. (15 mars 2024)
Phenotype and Reactivity of Lymphocytes Expanded from Benign Prostate Hyperplasic Tissues and Prostate Cancer.
R. Ahmed et al. (8 juin 2023)
Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumors.
J. Schmidt et al. (6 juin 2023)
TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRs.
R. Genolet et al. (24 avr. 2023)
Cancer vaccines based on whole-tumor lysate or neoepitopes with validated HLA binding outperform those with predicted HLA-binding affinity.
H. Fritah et al. (21 avr. 2023)
Longitudinal analysis of DC subsets in patients with ovarian cancer: Implications for immunotherapy.
A. Sarivalasis et al. (2023)
Estimated Costs of the Ipilimumab-Nivolumab Therapy and Related Adverse Events in Metastatic Melanoma.
B. Gautron Moura et al. (21 déc. 2022)
Sensitive identification of neoantigens and cognate TCRs in human solid tumors.
M. Arnaud et al.
The current clinical landscape of personalized cancer vaccines.
H. Fritah et al.
TEM1-targeting PEGylated PLGA shikonin nanoformulation for immunomodulation and eradication of ovarian cancer.
E.I. Matthaiou et al. (2022)
Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy.
F.G. Herrera et al.
Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation.
J. Duraiswamy et al. (13 déc. 2021)
Vaccines as Priming Tools for T Cell Therapy for Epithelial Cancers.
L.E. Kandalaft et al. (19 nov. 2021)
A Personalized Neoantigen Vaccine in Combination with Platinum-Based Chemotherapy Induces a T-Cell Response Coinciding with a Complete Response in Endometrial Carcinoma.
A. Harari et al. (18 nov. 2021)
Integrating Cancer Vaccines in the Standard-of-Care of Ovarian Cancer: Translating Preclinical Models to Human.
C.L. Chiang et al. (10 sept. 2021)
Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STING.
M. Bruand et al. (20 juil. 2021)
Rate of Freeze Impacts the Survival and Immune Responses Post Cryoablation of Melanoma.
C. Yakkala et al. (3 juin 2021)
Author Correction: Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancer.
J.L. Tanyi et al. (4 mai 2021)
Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancer.
J.L. Tanyi et al. (15 mars 2021)
Unsupervised Analysis of Flow Cytometry Data in a Clinical Setting Captures Cell Diversity and Allows Population Discovery.
P. Baumgaertner et al. (2021)
Deciphering the Mechanisms of Improved Immunogenicity of Hypochlorous Acid-Treated Antigens in Anti-Cancer Dendritic Cell-Based Vaccines.
M. Graciotti et al. (2 juin 2020)
Development and Optimization of a GMP-Compliant Manufacturing Process for a Personalized Tumor Lysate Dendritic Cell Vaccine.
C. Boudousquié et al. (14 janv. 2020)
Neutrophils suppress tumor-infiltrating T cells in colon cancer via matrix metalloproteinase-mediated activation of TGFβ.
M. Germann et al. (9 janv. 2020)
Predicting combinations of immunomodulators to enhance dendritic cell-based vaccination based on a hybrid experimental and computational platform.
R. Ahmed et al. (2020)

next